![](/img/cover-not-exists.png)
Open-Label Phase II Evaluation of Imatinib in Primary Inoperable or Incompletely Resected and Recurrent Glioblastoma
Sautter, Lisa, Hofheinz, Ralf, Tuettenberg, Jochen, Grimm, Mario, Vajkoczy, Peter, Groden, Christoph, Schmieder, Kirsten, Hochhaus, Andreas, Wenz, Frederik, Giordano, Frank A.Journal:
Oncology
DOI:
10.1159/000502483
Date:
September, 2019
File:
PDF, 225 KB
2019